NeOnc Technologies Expands into Middle East with AI-Powered Cancer Therapy Alliance | NewsOut

Oct 10, 2025

Biotech investors and health-tech innovators—NeOnc Technologies Holdings (NASDAQ: NTHI) has announced two major strategic developments to accelerate its global expansion and cancer therapy innovations.

Through its subsidiary Mina Holdings, NeOnc has signed a Master Services Agreement with Insights Research Organization and Solutions (IROS), part of the M42 Global Health Network, a UAE-based powerhouse leveraging AI and genomics for next-generation healthcare. At the same time, NeOnc is expanding the Neuro Mina Board of Directors by adding key partners from Quasar Investment, enhancing regional governance and growth.

This move anchors NeOnc’s research operations in one of the world’s most advanced healthcare ecosystems, fast-tracking clinical development of its cutting-edge cancer therapies.

🏷️ Tags:

#NeOncTechnologies
#BiotechInvesting
#CancerTherapy
#MiddleEastExpansion
#AIinHealthcare
#Genomics
#NeuroMina
#MinaHoldings
#QuasarInvestment
#M42GlobalHealth
#NASDAQNTHI
#StrategicPartnership
#NewsOut
#AnnaBerry